Colonoscopy is recommended for people over 45, but preparation turns off many. Here’s a look at how it compares to stool tests FIT and Cologuard.
Author: Karen Weintraub, USA TODAY
Thousands of babies and children are hospitalized by RSV every year. Why that could soon change.
Six drug companies are now developing RSV vaccines or antibodies, suggesting this year could be the last without adequate tools to fight the virus.
New guidelines expand eligibility for weight loss surgery. Will insurance coverage follow?
Two groups of bariatric surgeons want to expand eligibility for weight loss surgery. Whether insurance companies will agree remains to be seen.
A new treatment is restoring skin coloration to some with vitiligo. It’s giving patients hope.
A new study shows a treatment for vitiligo, which recently won FDA approval, restores natural skin color to one-third of patients.
These rats have human cells in their brains. They may help scientists understand autism and schizophrenia.
Stanford researcher Sergiu Pașca’s experiments, published Wednesday in the journal Nature, are both significant and ethically challenging.
FDA authorizes bivalent COVID-19 boosters for children ages 5 to 11
Children ages 5 to 11 can now get a COVID booster after the FDA authorized the bivalent dose Wednesday from both Pfizer-BioNTech and Moderna.
One big change is coming to clinical drug trials, and it’s ‘no longer lip service’
After the COVID-19 pandemic, a major and crucial change is coming to clinical drug trials: More diversity among research participants.
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.
The Food and Drug Administration on Thursday approved the use of Relyvrio to treat amyotrophic lateral sclerosis, more commonly known as ALS.
‘Food as medicine’: White House pilot program would bring medically tailored meals under Medicare
Medically tailored meals are one of many new programs proposed Tuesday by the Biden administration to reduce hunger and diet-related diseases.
FDA authorizes reformulated COVID-19 booster shot for the fall
The new booster shots could be available within days, after a CDC committee on Thursday recommends who should get them and its director signs off.